Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients

NCT01634061 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Castration-resistant Prostate Cancer

Interventions

DRUG: BEZ235
DRUG: BKM120
DRUG: BEZ235
DRUG: BKM120

Sponsor

Novartis Pharmaceuticals